References in periodicals archive ?
1) IPO-V2: a prospective, multicenter, randomized, comparative clinical investigation of the effects of sulodexide in preventing cardiovascular accidents in the first year after acute myocardial infarction.
During his presentation Professor Yves Vanrenterghem of Leuven University Hospital, Belgium, explained further that 40% of these deaths have cardiovascular accidents as an underlying cause (ie CV disease, myocardial infarction).

Full browser ?